Literature DB >> 33260434

Human Leukocyte Antigen (HLA) Haplotype Does Not Influence the Inflammatory Pattern of Duodenal Lymphocytosis Linked to Irritable Bowel Syndrome.

Giuseppe Losurdo1,2, Alessia Todeschini1, Floriana Giorgio1, Domenico Piscitelli3, Antonio Giangaspero1, Enzo Ierardi1, Alfredo Di Leo1.   

Abstract

Background and objectives: Duodenal lymphocytosis (DL) is a condition characterized by enhanced infiltration of intraepithelial lymphocytes (IELs) in the duodenal mucosa, and it can be linked to both gluten- and non-gluten-related diseases, such as irritable bowel syndrome (IBS). Materials and methods: We retrospectively selected patients with DL linked to IBS. Formalin-embedded biopsy samples of the duodenum were collected. CD3 lymphocyte immunohistochemistry was used for IELs. The real-time polymerase chain reaction was used to quantify the amount of mRNA coding for tissue transglutaminase 2 (tTG2), interferon-gamma (IFNγ), toll-like receptor 2 (TLR2), and myeloid differentiation primary response 88 (MyD88). All subjects underwent DQ2-8 haplotype analysis. Controls were represented by subjects with IBS without DL.
Results: Thirty-two patients with IBS-DL were retrospectively recruited. Fourteen subjects (43.8%) had a DQ2-8 haplotype. DQ2-8 positive subjects had similar levels compared to negative ones for tTG2, IFNγ, TLR2, and MyD88. Cigarette smoke did not influence molecular expression in our study. Smokers had a statistically higher IELs count than non-smokers (54.2 ± 7.7 vs. 36.0 ± 8.8, p < 0.001). A significant, direct correlation between IELs and duodenal expression of IFNγ was found (r = 0.36, p = 0.04). Conclusions: IBS with DL showed higher expression of inflammatory markers than controls, but DQ2-8 haplotype did not seem to affect their expression. Smoking might increase IELs infiltration.

Entities:  

Keywords:  duodenal lymphocytosis; inflammation; intraepithelial lymphocytes; irritable bowel syndrome; smoking

Mesh:

Substances:

Year:  2020        PMID: 33260434      PMCID: PMC7761368          DOI: 10.3390/medicina56120660

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  55 in total

1.  Celiac Disease is Misdiagnosed Based on Serology Only in a Substantial Proportion of Patients.

Authors:  Stephan R Vavricka; Teresa Stelzer; Jaqueline Lattmann; Matthias Stotz; Romina Lehmann; Jonas Zeitz; Michael Scharl; Benjamin Misselwitz; Daniel Pohl; Michael Fried; Radu Tutuian; Alessio Fasano; Alain M Schoepfer; Gerhard Rogler; Luc Biedermann; Thomas Greuter
Journal:  J Clin Gastroenterol       Date:  2018-01       Impact factor: 3.062

2.  Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up.

Authors:  Giuseppe Losurdo; Domenico Piscitelli; Antonio Giangaspero; Mariabeatrice Principi; Francesca Buffelli; Floriana Giorgio; Lucia Montenegro; Claudia Sorrentino; Annacinzia Amoruso; Enzo Ierardi; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

3.  Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome.

Authors:  Yasuhiro Fujiwara; Makiko Kubo; Yukie Kohata; Hirohisa Machida; Hirotoshi Okazaki; Hirokazu Yamagami; Tetsuya Tanigawa; Kenji Watanabe; Toshio Watanabe; Kazunari Tominaga; Tetsuo Arakawa
Journal:  Intern Med       Date:  2011-11-01       Impact factor: 1.271

4.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

5.  Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.

Authors:  Michael T Bethune; Matthew Siegel; Samuel Howles-Banerji; Chaitan Khosla
Journal:  J Pharmacol Exp Ther       Date:  2009-02-13       Impact factor: 4.030

6.  Mucosal cytokine imbalance in irritable bowel syndrome.

Authors:  John Macsharry; Liam O'Mahony; Aine Fanning; Emer Bairead; Graham Sherlock; Jay Tiesman; Andy Fulmer; Barry Kiely; Timothy G Dinan; Fergus Shanahan; Eamonn M M Quigley
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

7.  Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

Authors:  Giovanni Barbara; Vincenzo Stanghellini; Roberto De Giorgio; Cesare Cremon; Graeme S Cottrell; Donatella Santini; Gianandrea Pasquinelli; Antonio M Morselli-Labate; Eileen F Grady; Nigel W Bunnett; Stephen M Collins; Roberto Corinaldesi
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

8.  Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts' Criteria.

Authors:  Carlo Catassi; Luca Elli; Bruno Bonaz; Gerd Bouma; Antonio Carroccio; Gemma Castillejo; Christophe Cellier; Fernanda Cristofori; Laura de Magistris; Jernej Dolinsek; Walburga Dieterich; Ruggiero Francavilla; Marios Hadjivassiliou; Wolfgang Holtmeier; Ute Körner; Dan A Leffler; Knut E A Lundin; Giuseppe Mazzarella; Chris J Mulder; Nicoletta Pellegrini; Kamran Rostami; David Sanders; Gry Irene Skodje; Detlef Schuppan; Reiner Ullrich; Umberto Volta; Marianne Williams; Victor F Zevallos; Yurdagül Zopf; Alessio Fasano
Journal:  Nutrients       Date:  2015-06-18       Impact factor: 5.717

Review 9.  US perspective on gluten-related diseases.

Authors:  Maureen M Leonard; Brintha Vasagar
Journal:  Clin Exp Gastroenterol       Date:  2014-01-24

10.  May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis?

Authors:  Giuseppe Losurdo; Floriana Giorgio; Domenico Piscitelli; Lucia Montenegro; Claudia Covelli; Maria Grazia Fiore; Antonio Giangaspero; Andrea Iannone; Mariabeatrice Principi; Annacinzia Amoruso; Michele Barone; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.